郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

病毒感染mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents.

期刊：NPJ vaccines发表年份：2021作者：Susanne Rauch; Nicole Roth; Kim Schwendt; Mariola Fotin-Mleczek; Stefan O Mueller; Benjamin Petsch
阅读更多 →

病毒感染Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies.

期刊：Vaccines发表年份：2021作者：Ahmed Kandeil; Ahmed Mostafa; Rehab R Hegazy; Rabeh El-Shesheny; Ahmed El Taweel; Mokhtar R Gomaa; Mahmoud Shehata; Marawan A Elbaset; Ahmed E Kayed; Sara H Mahmoud; Yassmin Moatasim; Omnia Kutkat; Noha N Yassen; Marwa E Shabana; Mohamed GabAllah; Mi
阅读更多 →

病毒感染Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human Primates.

期刊：bioRxiv : the preprint server for biology发表年份：2021作者：Flavia Chiuppesi; Vu H Nguyen; Yoonsuh Park; Heidi Contreras; Veronica Karpinski; Katelyn Faircloth; Jenny Nguyen; Mindy Kha; Daisy Johnson; Joy Martinez; Angelina Iniguez; Qiao Zhou; Teodora Kaltcheva; Paul Frankel; Swagata Kar; Ankur Sharma; Hanne
阅读更多 →

病毒感染SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern.

期刊：bioRxiv : the preprint server for biology发表年份：2021作者：David W Hawman; Kimberly Meade-White; Jacob Archer; Shanna Leventhal; Drew Wilson; Carl Shaia; Samantha Randall; Amit P Khandhar; Tien-Ying Hsiang; Michael Gale; Peter Berglund; Deborah Heydenburg Fuller; Heinz Feldmann; Jesse H Erasmus
阅读更多 →